Calidi Biotherapeutics (Calidi Biotherapeutics) Interest Expense : $-0.80 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Calidi Biotherapeutics's interest expense for the three months ended in Mar. 2024 was $ -0.25 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.80 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Calidi Biotherapeutics's Operating Income for the three months ended in Mar. 2024 was $ -6.75 Mil. Calidi Biotherapeutics's Interest Expense for the three months ended in Mar. 2024 was $ -0.25 Mil. Calidi Biotherapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Calidi Biotherapeutics Interest Expense Historical Data

The historical data trend for Calidi Biotherapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Interest Expense Chart

Calidi Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

-0.16

-0.61

-0.16

-1.07

Calidi Biotherapeutics Quarterly Data
	Dec20	Sep21	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial					-0.22	-	-0.32	-0.22	-0.25

Calidi Biotherapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.80 Mil.

Calidi Biotherapeutics (AMEX:CLDI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Calidi Biotherapeutics's Interest Expense for the three months ended in Mar. 2024 was $-0.25 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-6.75 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $6.33 Mil.

Calidi Biotherapeutics's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Calidi Biotherapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037

Website

https://www.calidibio.com

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines

From GuruFocus

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

By ACCESSWIRE • 05-17-2024